SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,638,000 | +15.2% | 8,368 | 0.0% | 0.03% | -12.1% |
| Q2 2020 | $1,422,000 | +40.1% | 8,368 | -4.9% | 0.03% | -15.4% |
| Q1 2020 | $1,015,000 | +1.0% | 8,800 | 0.0% | 0.04% | +69.6% |
| Q4 2019 | $1,005,000 | +36.5% | 8,800 | +2.2% | 0.02% | +27.8% |
| Q3 2019 | $736,000 | +23.5% | 8,614 | 0.0% | 0.02% | +28.6% |
| Q2 2019 | $596,000 | -5.5% | 8,614 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $631,000 | -32.2% | 8,614 | -51.1% | 0.02% | -42.9% |
| Q4 2016 | $930,000 | – | 17,624 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |